FR22M - New drug in particular for the treatment of acute or chronic articular rheumatism. - Google Patents

New drug in particular for the treatment of acute or chronic articular rheumatism.

Info

Publication number
FR22M
FR22M FR832223A FR832223A FR22M FR 22 M FR22 M FR 22M FR 832223 A FR832223 A FR 832223A FR 832223 A FR832223 A FR 832223A FR 22 M FR22 M FR 22M
Authority
FR
France
Prior art keywords
acute
treatment
new drug
articular rheumatism
chronic articular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR832223A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Francais de Chimiotherapie SA
Original Assignee
Laboratoires Francais de Chimiotherapie SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR793081A external-priority patent/FR1344153A/en
Application filed by Laboratoires Francais de Chimiotherapie SA filed Critical Laboratoires Francais de Chimiotherapie SA
Priority to FR832223A priority Critical patent/FR22M/en
Application granted granted Critical
Publication of FR22M publication Critical patent/FR22M/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/07—Benzo[b]pyran-4-ones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
FR832223A 1959-04-24 1960-07-06 New drug in particular for the treatment of acute or chronic articular rheumatism. Expired FR22M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR832223A FR22M (en) 1959-04-24 1960-07-06 New drug in particular for the treatment of acute or chronic articular rheumatism.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR793081A FR1344153A (en) 1959-04-24 1959-04-24 New process for the preparation of 21-esters of 20-keto-steroids
FR832223A FR22M (en) 1959-04-24 1960-07-06 New drug in particular for the treatment of acute or chronic articular rheumatism.

Publications (1)

Publication Number Publication Date
FR22M true FR22M (en) 1961-01-06

Family

ID=39811721

Family Applications (1)

Application Number Title Priority Date Filing Date
FR832223A Expired FR22M (en) 1959-04-24 1960-07-06 New drug in particular for the treatment of acute or chronic articular rheumatism.

Country Status (1)

Country Link
FR (1) FR22M (en)

Similar Documents

Publication Publication Date Title
FR1444M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
FR1215M (en) New drug, in particular for the treatment of disorders due to hyperestrogenia or hypoandrogenia.
FR362M (en) New drug for the treatment of staphylococcal infections and salmonellosis.
BE582173A (en) Advanced device for the treatment of threads.
FR126M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR22M (en) New drug in particular for the treatment of acute or chronic articular rheumatism.
FR365M (en) New drug for the treatment of staphylococcal and streptococcal infections.
FR3066M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR363M (en) New drug for the treatment of trypanosomosis, salmonellosis and penicillofacial infections.
FR1878M (en) New polysaccharide, usable in therapy, in particular for the treatment of solid tumors.
FR3187M (en) New drug in particular for the treatment of irregularities and ovarian insufficiencies.
FR1204M (en) New drug, in particular for the treatment of chronic or post-prandial hyperlipemia.
FR385M (en) New drug for the treatment of staphylococcal infections and the like.
FR1172M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
FR2413M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
BE598672A (en) Therapeutic composition for the treatment of hepatic disorders.
FR2510M (en) New medicament usable for the treatment of staphylococcal infections and the like.
FR1456M (en) New drug in particular for the treatment of deficiencies of the corpus luteum.
BE630069A (en) Therapeutic composition for the treatment of parkinsonism.
FR2574M (en) New drug, in particular for the treatment of pain and inflammatory symptoms.
FR36M (en) New drug, in particular for the treatment of postprandial or acute hyperlipemia.
BE591743A (en) Therapeutic agents for the treatment of peptic ulcers
FR1412M (en) New drug in particular for the treatment of bronchitis, pneumonia, heart collapse and heart failure.
FR9M (en) New medicinal product in particular for the treatment of articular rheumatic affections, acute or chronic
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.